China's first in-human clinical trials of an invasive brain-computer interface (BCI) have launched, according to state media reports. This makes China second in the BCI race after the U.S., with its Neuralink technology, to enter the clinical trial phase for invasive BCI technology.
Ahead of upcoming larger-scale trials, this new BCI from the Shanghai-based Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) already seems to be a success. The country's Global Times states that a tetraplegic patient has already been using its BCI to control a computer, play racing games, play chess, and more.
